[HTML][HTML] Gut microbiota in neurological diseases: melatonin plays an important regulatory role
S Ahmadi, M Taghizadieh, E Mehdizadehfar… - Biomedicine & …, 2024 - Elsevier
Melatonin is a highly conserved molecule produced in the human pineal gland as a
hormone. It is known for its essential biological effects, such as antioxidant activity, circadian …
hormone. It is known for its essential biological effects, such as antioxidant activity, circadian …
[HTML][HTML] Parkinson's disease and gut microbiota: from clinical to mechanistic and therapeutic studies
X Zhang, B Tang, J Guo - Translational Neurodegeneration, 2023 - Springer
Parkinson's disease (PD) is one of the most prevalent neurodegenerative diseases. The
typical symptomatology of PD includes motor symptoms; however, a range of nonmotor …
typical symptomatology of PD includes motor symptoms; however, a range of nonmotor …
Metagenomics of the Gut Microbiome in Parkinson's Disease: Prodromal Changes
Objective Prior studies on the gut microbiome in Parkinson's disease (PD) have yielded
conflicting results, and few studies have focused on prodromal (premotor) PD or used …
conflicting results, and few studies have focused on prodromal (premotor) PD or used …
Gut microbiome correlates with plasma lipids in amyotrophic lateral sclerosis
Amyotrophic lateral sclerosis (ALS) is a complex, fatal neurodegenerative disease. Disease
pathophysiology is incompletely understood but evidence suggests gut dysbiosis occurs in …
pathophysiology is incompletely understood but evidence suggests gut dysbiosis occurs in …
[HTML][HTML] Diet and the gut microbiome in patients with Parkinson's disease
It has been suggested that gut microbiota influence Parkinson's disease (PD) via the gut–
brain axis. Here, we examine associations between diet and gut microbiome composition …
brain axis. Here, we examine associations between diet and gut microbiome composition …
[HTML][HTML] Gut Microbiota and Its Repercussion in Parkinson's Disease: A Systematic Review in Occidental Patients
AC Proano, JA Viteri, EN Orozco, MA Calle… - Neurology …, 2023 - mdpi.com
(1) Background: Parkinson's disease (PD) is a relatively common and complex pathology,
and some of its mechanisms remain to be elucidated. Change in host microbiota is related to …
and some of its mechanisms remain to be elucidated. Change in host microbiota is related to …
[HTML][HTML] Potential effects of the most prescribed drugs on the microbiota-gut-brain-axis: A review
K Garg, MH Mohajeri - Brain Research Bulletin, 2024 - Elsevier
The link between drug-induced dysbiosis and its influence on brain diseases through gut-
residing bacteria and their metabolites, named the microbiota-gut-brain axis (MGBA) …
residing bacteria and their metabolites, named the microbiota-gut-brain axis (MGBA) …
[HTML][HTML] Optimization of the Preparation Process of Glucuronomannan Oligosaccharides and Their Effects on the Gut Microbiota in MPTP-Induced PD Model Mice
B Wang, L Geng, J Wang, Y Wei, C Yan, N Wu, Y Yue… - Marine Drugs, 2024 - mdpi.com
Parkinson's disease (PD) is a prevalent neurodegenerative disorder, and accumulating
evidence suggests a link between dysbiosis of the gut microbiota and the onset and …
evidence suggests a link between dysbiosis of the gut microbiota and the onset and …
[HTML][HTML] Untargeted serum metabolomics reveals novel metabolite associations and disruptions in amino acid and lipid metabolism in Parkinson's disease
Background Untargeted high-resolution metabolomic profiling provides simultaneous
measurement of thousands of metabolites. Metabolic networks based on these data can …
measurement of thousands of metabolites. Metabolic networks based on these data can …
Evolution of Clinical, Biochemical and Microbiome Biomarkers of Conversion to Parkinson Disease in Glucocerebrosidase Mutation Carriers: Insights into Aetiology …
E Menozzi - 2024 - discovery.ucl.ac.uk
The penetrance of heterozygous variants in GBA1, the commonest genetic risk factor for
Parkinson disease (PD), is incomplete (10%-30%), but the reasons underlying this …
Parkinson disease (PD), is incomplete (10%-30%), but the reasons underlying this …